Rachel A Liberatore

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Recombinant Human

Top Venues

Emerging microbes & infections

This page only lists publications with an associated author ORCID identifier.

Publications

Debnath Maji, Verónica Miguela, Andrew D Cameron, Delcora A Campbell, Linda Sasset, Xin Yao, Andy T Thompson, Carleigh Sussman, David Yang, Robert Miller, Marek M Drozdz, Rachel A Liberatore
Enhancing In Vivo Electroporation Efficiency through Hyaluronidase: Insights into Plasmid Distribution and Optimization Strategies. Pharmaceutics 16 (4) (2024)
Debnath Maji, Verónica Miguela, Andrew D Cameron, Delcora A Campbell, Linda Sasset, Xin Yao, Andy T Thompson, Carleigh Sussman, David Yang, Robert Miller, Marek M Drozdz, Rachel A Liberatore
Enhancing In Vivo Electroporation Efficiency through Hyaluronidase: Insights into Plasmid Distribution and Optimization Strategies. Pharmaceutics 16 (4) (2024)
Chasity D Andrews, Yaoxing Huang, David D Ho, Rachel A Liberatore
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies. Emerging microbes & infections 9 (1) (2020)
Melissa Kane, Vincent Mele, Rachel A Liberatore, Paul D Bieniasz
Inhibition of spumavirus gene expression by PHF11. PLoS pathogens 16 (7) (2020)